<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Retinal-Amyloid-Imaging on 生物经济</title><link>https://cn.bioecon.ru/technologies/retinal-amyloid-imaging/</link><description>Recent content in Retinal-Amyloid-Imaging on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Mon, 20 Jul 2026 17:39:16 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/retinal-amyloid-imaging/index.xml" rel="self" type="application/rss+xml"/><item><title>神经退行性疾病视网膜生物标志物</title><link>https://cn.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/</guid><description>直接在视网膜中检测阿尔茨海默病及其他神经退行性疾病生物标志物的眼部扫描技术——无需对大脑本身成像即可窥视脑部病理的窗口——涵盖高光谱成像、基于OCT的结构性生物标志物与视网膜淀粉样蛋白检测：北美的 RetiSpec 与 NeuroVision Imaging，加拿大的 Optina Diagnostics，以及德国的 Heidelberg Engineering。</description></item></channel></rss>